UCB is a global biopharmaceutical company that discovers, develops, and commercializes medicines for serious neurological and immunological diseases. Its portfolio includes epilepsy therapies such as Keppra and Briviact, Cimzia for inflammatory conditions, and Bimzelx for psoriasis, sold through ...